These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 6184841
1. Effect of aspirin on platelet 5-hydroxytryptamine and beta-thromboglobulin plasma levels in patients with myeloproliferative diseases. Viero P, Cortelazzo S, Bassan R, Barbui T. Thromb Haemost; 1982 Oct 29; 48(2):125-6. PubMed ID: 6184841 [Abstract] [Full Text] [Related]
2. In vivo platelet release in myeloproliferative disorders. Ireland H, Lane DA, Wolff S, Foadi M. Thromb Haemost; 1982 Aug 24; 48(1):41-5. PubMed ID: 6215739 [Abstract] [Full Text] [Related]
3. Platelet activation in myeloproliferative disorders. Cortelazzo S, Viero P, Barbui T. Thromb Haemost; 1981 Jun 30; 45(3):211-3. PubMed ID: 6169172 [Abstract] [Full Text] [Related]
4. Plasma and platelet beta-thromboglobulin in chronic myeloproliferative disorders. Endo Y, Mamiya S, Satoh M. Nihon Ketsueki Gakkai Zasshi; 1981 Feb 30; 44(1):118-23. PubMed ID: 6171982 [No Abstract] [Full Text] [Related]
5. Clinical significance of beta-thromboglobulin in patients with high platelet count. Fabris F, Randi ML, Casonato A, Dal Bo Zanon R, Bonvicini P, Girolami A. Acta Haematol; 1984 Feb 30; 71(1):32-8. PubMed ID: 6197855 [Abstract] [Full Text] [Related]
6. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays. Lane DA, Ireland H, Wolff S, Ranasinghe E, Dawes J. Thromb Haemost; 1984 Oct 31; 52(2):183-7. PubMed ID: 6084323 [Abstract] [Full Text] [Related]
7. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy. Aushri Z, Berginer V, Nathan I, Dvilansky A. Int J Clin Pharmacol Res; 1983 Oct 31; 3(5):339-42. PubMed ID: 6206005 [Abstract] [Full Text] [Related]
10. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders. Malpass TW, Savage B, Hanson SR, Slichter SJ, Harker LA. J Lab Clin Med; 1984 Jun 31; 103(6):894-904. PubMed ID: 6233383 [Abstract] [Full Text] [Related]
16. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome]. Zuk E. Ann Acad Med Stetin; 1998 Jan 31; 44():137-54. PubMed ID: 9857536 [Abstract] [Full Text] [Related]
17. [Changes of beta-thromboglobulin levels in diabetic patients controlled with the artificial pancreas]. Voisin P, Rousselle D, Drouin P, Stoltz JF. Biomed Pharmacother; 1982 Jan 31; 36(1):19-23. PubMed ID: 6181821 [Abstract] [Full Text] [Related]
18. Platelet function and arachidonate metabolism in patients with myeloproliferative disorders. Okuma M. Nihon Ketsueki Gakkai Zasshi; 1980 Dec 31; 43(6):1139-44. PubMed ID: 6800179 [No Abstract] [Full Text] [Related]